Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT05608993
Eligibility Criteria:
Inclusion Criteria:
A. Secondary use data of encounters for children with AOM
1. Aged 2-17-years-old (inclusive)
2. Diagnosis of AOM by ICD10 code
3. AOM is uncomplicated
4. Prescribed an oral antibiotic
B. Clinician and administrator interviews
1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM
2. Practices in an intervention study site
3. Is not a medical trainee (student, resident, fellow, etc.)
4. Aged \>=18 years-no maximum
C. Parent focus groups
1. Parent or legal guardian of a child aged 2-17 years that has had AOM diagnosed at Vanderbilt University Medical Center or Washington University
2. 18 years of age or older and able/willing to consent
D. Clinician and administrator surveys
1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM
2. Practices in an intervention study site
3. Is not a medical trainee (student, resident, fellow, etc.)
4. Aged \>=18 years-no maximum
Exclusion Criteria:
A. Secondary use data of encounters for children with AOM
1\. Complicated infection (determined a priori)
B. Clinician and administrator interviews 1. Medical trainee
C. Parent focus groups
1. Not parent or legal guardian
2. Does not speak English or Spanish (focus groups can only be conducted in these languages).
D. Clinician and administrator surveys
1\. Medical trainee
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
17 Years
Study:
NCT05608993
Study Brief:
Protocol Section:
NCT05608993